Reverse Diabetes2 Now is a lifestyle treatment for people with type 2 diabetes, developed by Voeding Leeft. Using nutrition, exercise, sleep and relaxation as therapy, the 6 month programme aims to reduce medication intake, improve blood values (HbA1c) and give people a better quality of life. Check this 3 minute video to see our approach.

Scientific results after 12 months*

92% of participants fully or partially reversed their type 2 diabetes

Participant review score: 8,8

30% no longer use diabetes medication

More about our programme Continue reading

Find the latest international news update here. Topics amongst others: The Dutch Minister of Health in India to discuss Reverse Diabetes2 Now and first two groups have started in Hong Kong.

Participants of Reverse Diabetes2 Now

Reverse type2 diabetes documentary

“Documentary on the possibility of reversing type 2 diabetes”


“Also the Turkish cuisine could do with less carbohydrates. My family loves it too.”

Professor Diabetology of Leiden University Medical Center explains the possibility of reversing type 2 diabetes.

Prof. Dr. Hanno Pijl.

“Lifestyle is the only medicine that really works for diabetes type 2”

Programme dates and locations

Continue reading
Martijn van Beek
Founder and director Voeding Leeft
"Type 2 diabetes is a growing problem across the globe, with over 425 million people suffering from the disease. Voeding Leeft, initiator of the Reverse Diabetes2 Now program, has been approached by several hospitals and insurance companies in India, Hong Kong and China to pilot the programme in those countries/regions, helping to find a way to reverse the diabetes trend globally through lifestyle. The first pilot is expected to start this autumn."

*Louis Bolk Institute report “4th intermediate results of Keer Diabetes2 Om”. Scientific research measuring the effect of the Reverse Diabetes2 Now programme of Voeding Leeft in The Netherlands, together with health Insurance partner VGZ. Publication in preparation. The report is based on participants from whom data is available. Because of loss to follow up and the stepped care model, the number of results per datapoint may vary.